跳至主要内容
临床试验/NCT03011827
NCT03011827Unknown不适用

Transfusion Prediction Model in Orthotopic Liver Transplantation Based on Thromboelastometry: Prospective Validation Study.

Hospital Clinic of Barcelona2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2019年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
65
试验地点
2
主要终点
Red blood cell transfusion

研究概览

简要总结

Thromboelastometry better assess coagulation than standard coagulation test in patients undergoing ortothopic liver transplantation. In a post-hoc analysis from a randomized study recently conducted by our group, presurgical values of MA10 Extem < 35 mm are highly predictive of RBC administration , with no further improvement over MA10 Extem >40 mm ; suggesting that MA10 Extem between 35-40 would be the optimal range to manage blood product administration. The aim of the study is to validate this result in a prospective cohort of patients submitted to ortothopic liver transplantation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presurgical hemoglobin < 13 d/L and clot firmness at 10 minutes Extem < 35 mm

排除标准

  • Previous thrombosis
  • Antithrombotic treatment
  • No consent

研究组 & 干预措施

Prospective cohort

Experimental

Fibrinogen and/or platelet administration

干预措施: Fibrinogen and/or platelets administration (Other)

结局指标

主要结局

Red blood cell transfusion

时间窗: until 24h after liver transplant

次要结局

  • Thrombosis(28 days after liver transplant)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Annabel Blasi

Anesthesiologist

Hospital Clinic of Barcelona

研究点 (2)

Loading locations...

相似试验